The latest news on research, treatment, prevention and education from the
state's only National Cancer Institute-designated Comprehensive Cancer Center

Personalizing Cancer Treatments for the Youngest of Patients

The aim of personalizing cancer treatments by targeting genomic mutations in cancer has seen rapid advances in recent years mainly for adult patients. Recognizing a need to further explore genomic profiling in pediatric malignancies, the Hugs for Brady Foundation has committed $300,000 to the precision medicine initiative at Rutgers Cancer Institute of New Jersey, which will help support research being conducted by Associate Director for Translational Science Shridar Ganesan, MD, PhD.Learn more

Surviving Ovarian Cancer: Attacking Drug Resistant Cancer Cells

A new targeted drug delivery system is successfully treating late-stage ovarian cancer in laboratory models. Lorna Rodriguez, MD, PhD, head of the precision medicine initiative at Rutgers Cancer Institute of New Jersey and professor of obstetrics, gynecology and reproductive sciences at Rutgers Robert Wood Johnson Medical School; and Rutgers scientist and Cancer Institute member Tamara Minko, PhD, are collaborating on research aimed at attacking drug resistant cancer cells.Learn more

Lung Cancer Prevention a Key Focus

With the arrival of a new year, you may decide that this is the year to reduce your risk for lung cancer. If quitting smoking is one of your resolutions, the Tobacco Dependence Program (TDP) supported by the Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School and Rutgers School of Public Health can help with individual assessments, group support and physician consultation. Complementing the TDP in its efforts, the Thoracic Oncology Program at the Cancer Institute is now offering low-cost lung cancer screenings in collaboration with Robert Wood Johnson University Hospital and University Radiology.Learn more

Cervical Cancer: One of the Deadliest but most Preventable Cancers

According to the National Cancer Institute, cervical cancer is the third most common cancer in women worldwide. Fortunately, in the U.S., the incidence of cervical cancer has decreased significantly over the last 50 years. Sara Isani, MD, a gynecologic oncologist at Rutgers Cancer Institute of New Jersey and assistant professor of obstetrics, gynecology and reproductive sciences at Rutgers Robert Wood Johnson Medical School, is trained in minimally invasive robotic surgical approaches and offers evaluation for a wide array of reproductive cancers including cervical cancer. She explains the importance of Pap smears, the HPV vaccine and a preventative lifestyle in helping to combat this disease in a recently published article.Learn more